- İstanbul Больница Флоренс Найтингейл
- 2013 Стамбульская больница Флоренс Найтингейл Профессор, доктор, кафедра офтальмологии
- 2013 Шишли Больница Флоренс Найтингейл Доцент кафедры офтальмологии
- 2005 Стамбульский университет, экспериментальный медицинский исследовательский институт Отделение исследований и применения метаболизма и диабета, глазные болезни - доцент
- 2005 Стамбульский университет Стамбульский медицинский факультет Врач-консультант отделения неонатологии педиатрической клиники
- 2005 Научно-исследовательский институт экспериментальной медицины Стамбульского университета Преподаватель кафедры иммунологии, магистратуры и докторантуры
- 2004 Стамбульский университет Врач-консультант, отделение внутренних болезней, отделение диабета
- 2000 Стамбульский университет, DETAE Врач-специалист в отделе исследований и применения метаболизма и диабета
- 1994 Стамбульский университет Врач-специалист отделения офтальмологии
- 1991 Стамбульский университет Научный сотрудник кафедры офтальмологии
- 1986 Стамбульский университет Медицинское образование
-
• Турецкая ассоциация офтальмологов, отделение сетчатки
• Турецкая медицинская ассоциация
• Турецкий диабетический фонд (член-основатель)
• Американская диабетическая ассоциация (ADA)
• Европейская ассоциация по изучению диабета (EASD)
• 2004-2007 Ассоциация по жизни с диабетом, генеральный президент
• 2007-2012 Международная федерация диабета Европы (IDF-Europe) Член правления
• Избранный президент Международной федерации диабета Европы (IDF-Europe) 2012-2015
• 2014-2017 Член Совета Европейской ассоциации по изучению диабета (EASD)
• Президент Международной федерации диабета Европы (IDF-Europe) 2015-2019
• 2018 г. — член правления Турецкого диабетического фонда
• 2019 г. — генеральный президент Ассоциации людей, живущих с диабетом.
-
• Karadeniz S, Kır N, Yılmaz MT, Öngör E, Dinççag N, Başar D, Akarçay K, Satman İ, Devrim AS: Alteration of visual function in impaired glucose tolerance. European Journal of Ophthalmology 1996; 6(1): 59-62
• Andel M, Bolli BG, Boulton AJM, Bozikov V, Car N, Christov V, Corcos A, Del Prato S, Drzewoski J, Fövenyi J, Hancu N, Hanefeld M, Harman-Boehm I, Heine RJ, İlkova H, İmamoğlu S, Ionescu-Tirgoviste C, Jermendy G, Karadeniz Ş, King H, Koev D, Norkus A, Perusicova P, Ravnik-Oblak M, Raz I, Serban V, Sieradzki J, Skrha J, Sulcaite R, Taton J, Temelkova-Kurktschiev T, Tkac I, Vozar J, Vrhovac B, Vrtovec M, Yılmaz T: Recommendations for the management of patients with type 2 diabetes mellitus in the Central, Eastern and Southern European Region. Consensus Statement. Update, International Journal for Postgraduate Training in Medicine 2000; 8: 3-26
• Satman I, Yilmaz MT, Gursoy N, Karsidag K, Dinccag N, Ovali T, Karadeniz S, Uysal V, Bugra Z, Otken A, Devrim S: Evaluation of insulin resistant diabetes mellitus in Alstrom syndrome.: a long-term prospective follow-up of three siblings. Diabetes Res Clin Pract 2002; 56(3): 189-196
• Karadeniz S, Yılmaz MT: Duration of diabetes and prevalence of diabetic retinopathy: Istanbul Diabetic Retinopathy Study-IDRS results 1. Diabetes & Metabolic Syndrome: Clinical Research and Reviews 2007; 1: 43-48
• Paulweber B, Valensi P, Lindström J, Lalic NM, Greaves CJ, McKee M, Kissimova-Skarbek K, Liatis S, Cosson E, Szendroedi J, Sheppard KE, Charlesworth K, Felton AM, Hall M, Rissanen A, Tuomilehto J, Schwarz PE, Roden M, Paulweber M, Stadlmayr A, Kedenko L, Katsilambros N, Makrilakis K, Kamenov Z, Evans P, Gilis-Januszewska A, Lalic K, Jotic A, Djordevic P, Dimitrijevic-Sreckovic V, Hühmer U, Kulzer B, Puhl S, Lee-Barkey YH, AlKerwi A, Abraham C, Hardeman W, Acosta T, Adler M, AlKerwi A, Barengo N, Barengo R, Boavida JM, Charlesworth K, Christov V, Claussen B, Cos X, Cosson E, Deceukelier S, Dimitrijevic-Sreckovic V, Djordjevic P, Evans P, Felton AM, Fischer M, Gabriel-Sanchez R, Gilis-Januszewska A, Goldfracht M, Gomez JL, Greaves CJ, Hall M, Handke U, Hauner H, Herbst J, Hermanns N, Herrebrugh L, Huber C, Hühmer U, Huttunen J, Jotic A, Kamenov Z, Karadeniz S, Katsilambros N, Khalangot M, Kissimova-Skarbek K, Köhler D, Kopp V, Kronsbein P, Kulzer B, Kyne-Grzebalski D, Lalic K, Lalic N, Landgraf R, Lee-Barkey YH, Liatis S, Lindström J, Makrilakis K, McIntosh C, McKee M, Mesquita AC, Misina D, Muylle F, Neumann A, Paiva AC, Pajunen P, Paulweber B, Peltonen M, Perrenoud L, Pfeiffer A, Pölönen A, Puhl S, Raposo F, Reinehr T, Rissanen A, Robinson C, Roden M, Rothe U, Saaristo T, Scholl J, Schwarz PE, Sheppard KE, Spiers S, Stemper T, Stratmann B, Szendroedi J, Szybinski Z, Tankova T, Telle-Hjellset V, Terry G, Tolks D, Toti F, Tuomilehto J, Undeutsch A, Valadas C, Valensi P, Velickiene D, Vermunt P, Weiss R, Wens J, Yilmaz T: A European evidence-based guideline for the prevention of type 2 diabetes. Horm Metab Res 2010; 42 (Suppl 1): S3-S36
• Lindström J, Neumann A, Sheppard KE, Gilis-Januszewska A, Greaves CJ, Handke U, Pajunen P, Puhl S, Pölönen A, Rissanen A, Roden M, Stemper T, Telle-Hjellset V, Tuomilehto J, Velickiene D, Schwarz PE, Acosta T, Adler M, AlKerwi A, Barengo N, Barengo R, Boavida JM, Charlesworth K, Christov V, Claussen B, Cos X, Cosson E, Deceukelier S, Dimitrijevic-Sreckovic V, Djordjevic P, Evans P, Felton AM, Fischer M, Gabriel-Sanchez R, Gilis-Januszewska A, Goldfracht M, Gomez JL, Greaves CJ, Hall M, Handke U, Hauner H, Herbst J, Hermanns N, Herrebrugh L, Huber C, Hühmer U, Huttunen J, Jotic A, Kamenov Z, Karadeniz S, Katsilambros N, Khalangot M, Kissimova-Skarbek K, Köhler D, Kopp V, Kronsbein P, Kulzer B, Kyne-Grzebalski D, Lalic K, Lalic N, Landgraf R, Lee-Barkey YH, Liatis S, Lindström J, Makrilakis K, McIntosh C, McKee M, Mesquita AC, Misina D, Muylle F, Neumann A, Paiva AC, Pajunen P, Paulweber B, Peltonen M, Perrenoud L, Pfeiffer A, Pölönen A, Puhl S, Raposo F, Reinehr T, Rissanen A, Robinson C, Roden M, Rothe U, Saaristo T, Scholl J, Schwarz PE, Sheppard KE, Spiers S, Stemper T, Stratmann B, Szendroedi J, Szybinski Z, Tankova T, Telle-Hjellset V, Terry G, Tolks D, Toti F, Tuomilehto J, Undeutsch A, Valadas C, Valensi P, Velickiene D, Vermunt P, Weiss R, Wens J, Yilmaz T: Take action to prevent diabetes-theIMAGE toolkit for the prevention of type 2 diabetes in Europe. Horm Metab Res 2010; 42 (Suppl 1): S37-S55
• Pajunen P, Landgraf R, Muylle F, Neumann A, Lindström J, Schwarz PE, Peltonen M, Acosta T, Adler M, AlKerwi A, Barengo N, Barengo R, Boavida JM, Charlesworth K, Christov V, Claussen B, Cos X, Cosson E, Deceukelier S, Dimitrijevic-Sreckovic V, Djordjevic P, Evans P, Felton AM, Fischer M, Gabriel-Sanchez R, Gilis-Januszewska A, Goldfracht M, Gomez JL, Greaves CJ, Hall M, Handke U, Hauner H, Herbst J, Hermanns N, Herrebrugh L, Huber C, Hühmer U, Huttunen J, Jotic A, Kamenov Z, Karadeniz S, Katsilambros N, Khalangot M, Kissimova-Skarbek K, Köhler D, Kopp V, Kronsbein P, Kulzer B, Kyne-Grzebalski D, Lalic K, Lalic N, Landgraf R, Lee-Barkey YH, Liatis S, Lindström J, Makrilakis K, McIntosh C, McKee M, Mesquita AC, Misina D, Muylle F, Neumann A, Paiva AC, Pajunen P, Paulweber B, Peltonen M, Perrenoud L, Pfeiffer A, Pölönen A, Puhl S, Raposo F, Reinehr T, Rissanen A, Robinson C, Roden M, Rothe U, Saaristo T, Scholl J, Schwarz PE, Sheppard KE, Spiers S, Stemper T, Stratmann B, Szendroedi J, Szybinski Z, Tankova T, Telle-Hjellset V, Terry G, Tolks D, Toti F, Tuomilehto J, Undeutsch A, Valadas C, Valensi P, Velickiene D, Vermunt P, Weiss R, Wens J, Yilmaz T: Quality indicators for the prevention of type 2 diabetes in Europe-IMAGE. Horm Metab Res 2010; 42 (Suppl 1): S56-S63
• European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren WM, Albus C, Benlian P, Boysen G, Cifkova R, Deaton C, Ebrahim S, Fisher M, Germano G, Hobbs R, Hoes A, Karadeniz S, Mezzani A, Prescott E, Ryden L, Scherer M, Syvänne M, Scholte Op Reimer WJ, Vrints C, Wood D, Zamorano JL, Zannad F. Atherosclerosis. 2012 Jul;223(1):1-68.
• European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren WM, Albus C, Benlian P, Boysen G, Cifkova R, Deaton C, Ebrahim S, Fisher M, Germano G, Hobbs R, Hoes A, Karadeniz S, Mezzani A, Prescott E, Ryden L, Scherer M, Syvanne M, Scholte Op Reimer WJ, Vrints C, Wood D, Zamorano JL, Zannad F; Avrupa Kardiyoloji Derneği ile Klinik Uygulamada; Kardiyovasküler Hastaliklardan Korunma Üzerinde Çalişan Diğer Derneklerin Beşinci Birleşik Görev Grubu (dokuz derneğin temsilcileri ve davet edilmiş uzmanlardan oluşmaktadir; Avrupa Kardiyovasküler Korunma and Rehabilitasyon (EACPR); özel Katkisi ile geliştirilmiştir. Turk Kardiyol Dern Ars 2012; 40 (Suppl 3): 1-76
• European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren WM, Albus C, Benlian P, Boysen G, Cifkova R, Deaton C, Ebrahim S, Fisher M, Germano G, Hobbs R, Hoes A, Karadeniz S, Mezzani A, Prescott E, Ryden L, Scherer M, Syvänne M, Scholte Op Reimer WJ, Vrints C, Wood D, Zamorano JL, Zannad F; European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Int J Behav Med 2012; 19(4): 403-488
• Hernandez C, Simo R; European Consortium for the Early Treatment of Diabetic Retinopathy (EUROCONDOR) (Arce R, Bandello F, Burks D, Cunha-Vaz J, Egan C, Garcia-Arumi J, Gibson J, Harding SP, Karadeniz S, Lang G, Massin P, Midena E, Ponsati B, Porta M, Scanlon P, Simo R, Sjoie AK, Valverde AM). Neurodegeneration is an early event in diabetic retinopathy: therapeutic implications. Br J Ophthalmol 2012; 96(10): 1285-1290
• European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): the Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Fifth Joint Task Force of the European Society of Cardiology; European Association of Echocardiography; European Association of Percutaneous Cardiovascular Interventions; European Heart Rhythm Association; Heart Failure Association; European Association for Cardiovascular Prevention & Rehabilitation; European Atherosclerosis Society; International Society of Behavioural Medicine; European Stroke Organisation; European Society of Hypertension; European Association for the Study of Diabetes; European Society of General Practice/Family Medicine; International Diabetes Federation Europe (Karadeniz S); European Heart Network. Eur J Prev Cardiol. 2012 Aug;19(4):585-667
• European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): the Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, Albus C, Benlian P, Boysen G, Cifkova R, Deaton C, Ebrahim S, Fisher M, Germano G, Hobbs R, Hoes A, Karadeniz S, Mezzani A, Prescott E, Ryden L, Scherer M, Syvänne M, Scholte op Reimer WJ, Vrints C, Wood D, Zamorano JL, Zannad F. Eur Heart J. 2012 Jul;33(13):1635-1701. doi: 10.1093/eurheartj/ehs092. Epub 2012 May 3. No abstract available. Erratum in: Eur Heart J. 2012 Sep;33(17):2126.
• European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren WM, Albus C, Benlian P, Boysen G, Cifkova R, Deaton C, Ebrahim S, Fisher M, Germano G, Hobbs R, Hoes A, Karadeniz S, Mezzani A, Prescott E, Ryden L, Scherer M, Syvanne M, Scholte Op Reimer WJ, Vrints C, Wood D, Zamorano JL, Zannad F; Comitato per Linea Guida Pratiche (CPG) dell’ESC. G Ital Cardiol (Rome) 2013; 14(5): 328-392
• Hernandez C, Simo R; European Consortium for the Early Treatment of Diabetic Retinopathy (EUROCONDOR) (Bandello F, Burks D, Cunha-Vaz J, Egan C, Garcia-Arumi J, Gibson J, Harding SP, Karadeniz S, Lang G, Massin P, Midena E, Ponsati B, Porta M, Scanlon P, Simo R, Sjoie AK, Valverde AM). Somatostatin replacement: a new strategy for treating diabetic retinopathy. Curr Med Chem 2013; 20(26): 3251-3257
• Simo R, Hernandez C; European Consortium for the Early Threatment of Diabetic Retinopathy (EUROCONDOR) (Bandello F, Burks D, Cunha-Vaz J, Egan C, Garcia-Arumi J, Gibson J, Harding SP, Karadeniz S, Lang G, Massin P, Midena E, Ponsati B, Porta M, Scanlon P, Simo R, Grausland J, Valverde AM). Neurodegeneration in the diabetic eye: new insights and therapeutic perspectives. Trends Endocrinol Metab 2014; 25(1): 23-33
• Ibrahim M, Abu Al Magd M, Annabi FA, Assaad-Khalil S, Ba-Essa EM, Fahdil I, Karadeniz S, Meriden T, Misha’l AA, Pozzili P, Shera S, Thomas A, Bahijri S, Tuomilehto J, Yilmaz T, Umpierrez GE. Recommendations for management of diabetes during Ramadan: update 2015. BMJ Open Diabetes Res Care 2015; 3(1): e000108
• Health Consumer Powerhouse 2013 Euro Vision Scorecard Report. Eds Hjertqvist J, Björnberg A. External expert panel Banks I, Güell JL, Karadeniz S, Larsen M, Nevin M. Health Consumer Powerhouse Ltd 2013
• Yilmaz MT, Karadeniz S. Prediabetes and diabetes prevention initiatives in Turkey. Ch 18. In: Global Health Perspectives in Prediabetes and Diabetes Prevention. Ed: Bergman M. World Scientific Publishing Co. Pte.Ltd. 2014; p.407-30
• Karadeniz S, Zimmet P,Aschner P, Belton A, Cavan D, Jalang’o A, Gandhi N, Hill L, Makaroff L, Le Mesurier R, Patel B, Porta M, Taylor H.International Diabetes Federation and Fred Hollows Foundation. Diabetes Eye Health. A guide for health care professionals. (Co-chairs: Karadeniz S, Zimmet P.) Brussels, Belgium. International Diabetes Federation 2015
• Integrating diabetes evidence into practice: Challenges and opportunities to bridge the gaps. Eds: Khunti K, Andriciuc, Karadeniz S, Lalic N, Makrilakis K, Pall N, Quinn L, Saraheimo M, Vlasenko I. CInternational Diabetes Federation Euorope 2017
• Karadeniz Ş, Ovalı T, Öngör E: Diyabetik retinopati takibinde kullanılan yöntemler. 2. Baskı. In: Diyabetolojiye Giriş Laboratuar ve Klinik Tanı Kriterlerinin Standardizasyonu. Eds: Büyükdevrim AS, Yılmaz MT, Satman İ, Dinççağ N, Karşıdağ K, Altuntaş Y. Fatih Ofset Matbaası, İstanbul. s.117-25, 1996
• Akalın S, Aslan M, Başkal N, Çorakçı A, Dinççağ N, Erbaş T, Hatun Ş, İlkova H, İmamoğlu Ş, Karadeniz Ş, Korugan Ü, Özer E, Tuncel E, Yeşil S, Yılmaz C, Yılmaz MT: Diabetes Mellitus 2000. Yılmaz C, Yılmaz MT, İmamoğlu Ş (Eds). Gri Tasarım, İstanbul, 2000
• Karadeniz Ş: Diyabetik retinopati ve tedavisi. In: Diabetes Mellitus’un Modern Tedavisi. Yılmaz MT, Bahçeci M, Büyükbeşe A (Eds). Özlem Grafik Matbaacılık, İstanbul. 2004; s.123-128
• Karadeniz Ş. Diabetik retinopati. İç Hastalıkları Kitabı 1.Cilt. Ed: Büyüköztürk K. Ed. Yard: Atamer T, Dilmener M, Erzengin F, Kaysı A, Ökten A. Nobel Tıp Kitabevi 2007; s.561-64
• Karadeniz Ş. Diyabet ve göz. Sorularla Diyabet. Ed: Yılmaz MT. Mart Matbaacılık Sanatları 2008; s.46-49
• Diyabet Tanı ve Tedavi Rehberi. Eds: M.T. Yılmaz, A. Kaya, M.K. Balcı, İ. Yetkin, A. Çömlekçi, M. Sargın, E. Özer, Ş. Karadeniz. Portakal Basım Matbaacılık San. Tic. Ltd. Şti. İstanbul 2011
• Taşlıpınar A, Çorakçı A, Kaya A, Uysal AR, Tuzcu A, Sönmez A, Kut A, Gemalmaz A, Çıkım Sertkaya A, Atmaca A, Çakır B, Çetinarslan B, İlhan B, Tokgöz B, Gökçe C, Özdemir D, Gogaz Yavuz D, Ural D, Er E, Ertörer E, Orbay E, Özer E, Akal Yıldız E, Karakurt F, Bayraktar F, Sipahioğlu F, Eminsoy G, Kızıltan G, Bilen H, Kahraman H, İlkova H, Onat H, Sebile Dökmetaş H, Gökmen Özel H, Tonbul HZ, Şahin İ, Ünlüoğlu İ, Tarkun İ, Yetkin İ, Marakoğlu K, Kebapçılar L, Yılmaz MT, Sargın M, Çakır M, Kayıkçıoğlu M, Yılmaz M, Girginer M, Şahin M, Kulaksızoğlu M, Cesur M, Araz M, Balcı MK, Kutlu M, Özyazar M, Olgun N, Deyneli O, Azal Ö, Sarı R, Çolak R, Sancak S, Çelik SG, Karadeniz Ş, Yücel T, Özkan Y, Cantürk Z. Ulusal Diyabet Konsensus Grubu, Diyabet Tanı ve Tedavi Rehberi 2016. Türkiye Diyabet Vakfı. Eds: Yılmaz MT, Kaya A, Balcı MK, Bayraktar F, Dağdelen S, Şahin İ, Sargın M. Armoni Nüans Baskı Sanatları A.Ş., İstanbul 2016
• Çorakçı A, Kaya A, Tuzcu AK, Akıncı B, Güney E, Akarsu E, Yıldız E, Bayram F, Bayraktar F, Bilen H, İlkova H, Şahin İ, Yetkin İ, Gül K, Karşıdağ K, Yılmaz MT, Sargın M, Ertörer ME, Yılmaz M, Araz M, Balcı MK, Başkal N, Deyneli O, Azal Ö, Sarı R, Çolak R, Dağdelen S, Güllü S, Karadeniz Ş, Bayraktaroğlu T, Sabuncu T, Erbaş T, Altuntaş Y, Oşar Siva Z, Kebapçılar L, Kulaksızoğlu L, Bakıner OS, Alkan İT, Bardakçı AZ, Özkan MA. Ulusal Diyabet Konsensus Grubu, Diyabet Tanı ve Tedavi Rehberi 2018. Türkiye Diyabet Vakfı. Eds: Yılmaz MT, Kaya A, Balcı MK, Karadeniz Ş, Dağdelen S, Şahin İ, Sargın M. Ege Reklam Basım Sanatları San Tic Ltd Şti, İstanbul 2018
-
• Медаль BlackSeaDiab, 1996 г., Яссы, Румыния.
• 1999 XII Конгресс Европейского общества офтальмологов, Стокгольм, Швеция Премия Сантэна за лучший постер по детской офтальмологии, косоглазию и прочему Карадениз С. «Скрининг ретинопатии недоношенных. Должны ли мы снова корректировать верхние пределы?»
• 2002 Национальный конгресс по диабету, Стамбул, Турецкий диабетический фонд, Международная научная публикация по сахарному диабету (авторизация) Премия за поддержку Карадениз С., Йылмаз М.Т. «Возраст начала диабета: является ли он одним из определяющих факторов диабетической ретинопатии при диабете 2 типа». Диабетология 2001 ; 44(Приложение 1): A286
• 2006 Национальный конгресс по диабету, Анталья, Турецкий диабетический фонд, Международная научная публикация по сахарному диабету (согласно материалам) Премия за поддержку Карадениз С., Йылмаз М.Т. «Гипертония: фактор риска непролиферативной диабетической ретинопатии и диабетической макулопатии, угрожающей зрению» EASD Гипертония в Сборник тезисов встречи группы по изучению диабета, 2005 г.
• 2007 Национальный конгресс по диабету, Анталья, Фонд диабета Турции, Международная научная публикация по сахарному диабету (согласно материалам) Поддержка Вторая премия Карадениз С., Йылмаз М.Т. «Длительность диабета при начале диабетической ретинопатии у пациентов с диабетом 1-го и 2-го типа» Диабетическая медицина, 2006, 23 (Приложение 4): P2050, 713-714
Назначить встречу
Электронный результат
Позвольте нам позвонить вам